1 - ArticleWe here emphasize that the surface enhanced Raman scattering (SERS) intensity has to be optimized by choosing the appropriate gold nanoparticles size for two excitation wavelengths; 632.8 and 785 nm. We discuss the role of the position and of the order of the localized surface plasmon resonance (LSPR) in such optimization for both wavelengths. At 632.8 nm, the best SERS intensity is reached for a LSPR located between the excitation and Raman wavelengths whereas at 785 nm, the LSPR should be placed outside this range. The third order of LSPR is shown to have no influence on the SERS intensity. (C) 2010 American Institute of Physics
In this paper we highlight the accurate spectral detection of bovine serum albumin and ribonuclease-A using a surface-enhanced Raman scattering (SERS) substrate based on gold nanocylinders obtained by electron-beam lithography (EBL). The nanocylinders have diameters from 100 to 180 nm with a gap of 200 nm. We demonstrate that optimizing the size and the shape of the lithographed gold nanocylinders, we can obtain SERS spectra of proteins at low concentration. This SERS study enabled us to estimate high enhancement factors (10(5) for BSA and 10(7) for RNase-A) of important bands in the protein Raman spectrum measured for 1 mM concentration. We demonstrate that, to reach the highest enhancement, it is necessary to optimize the SERS signal and that the main parameter of optimization is the LSPR position. The LSPR have to be suitably located between the laser excitation wavelength, which is 632.8 nm, and the position of the considered Raman band. Our study underlines the efficiency of gold nanocylinder arrays in the spectral detection of proteins.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.